search results for 

Fresenius shares

Market conditions featured great uncertainty and high volatility in the first half of 2012, but the Fresenius share was not much affected. The share price initially benefited from excellent operating results as well as the completion of major acquisitions. Until mid-year, the price moved laterally but increased sharply over the summer. Driven by positive market sentiment and expectations of solid quarterly results, the Fresenius share hit a new high of €96.38 on October 16, 2012. In view of the more cautious outlook for the year announced by Fresenius Medical Care, the share price decreased. The closing price for the Fresenius share on December 31, 2012 was €87.10. This represents a gain of 22% over the closing price for 2011. In a comparison over three years, the Fresenius share outperformed its benchmark DAX by 72%, as may be seen on the chart above. The DAX was up by only 28% over this period, but the Fresenius share doubled in price.

Fresenius’ market capitalization was €15.5 billion as of December 31, 2012, an increase of 33% compared to December 31, 2011.

As the table shows, the average daily trading volume in Fresenius shares on Xetra decreased by 4% compared to the previous year. DAX trading volume decreased by 6% in the same time period.


  Average trading volume 2012 No. of shares/day Average trading volume 2011 No. of shares/day Change in %
Fresenius share 482,030 502,241 -4

  Average trading volume 2012 No. of shares/day Average trading volume 2011 No. of shares/day Change in %
Fresenius share 482,030 502,241 -4

The Fresenius share is listed on the stock exchanges in Frankfurt am Main, Düsseldorf, and Munich. Fresenius is included in Germany’s leading index, the DAX, as well as the Prime Standard Pharma & Healthcare index, and the Dow Jones Stoxx 600 Healthcare index. The Fresenius share is also listed in the Dow Jones Euro Stoxx and the FTSE Eurofirst 300 indices.


Fresenius completed a capital increase in May 2012. The new shares were placed with institutional investors through an accelerated book built offering. In connection with the capital increase, 13.8 million new ordinary shares were issued at a price of €73.50 per share. The new shares have full dividend entitlement for the fiscal year 2012. After issuance of the new shares, the total number of outstanding ordinary shares of Fresenius SE & Co. KGaA increased from 163,366,002 to 177,166,002.

Furthermore, stock options under the 1998, 2003, and 2008 stock option plans were exercised in 2012. Further information on the stock option plans can be found in the Notes of this Annual Report.

The number of shares increased by 14,950,924 to a total of 178,188,260 shares by the end of 2012.

Back to:
Stock markets
Continue reading:
ADR program